In a major development, the Government of India has finalised arrangements with Hyderabad-based vaccine manufacturer Biological-E to reserve 30 crore of COVID-19 vaccine doses for the country. As per reports, these vaccine doses will be manufactured and stockpiled by Biological-E from August to December 2021.
According to sources, the Union Health Ministry of Health would be making an advance payment of Rs 1500 crore to the manufacturer for this purpose.
Among the many vaccine candidates in India, Biological-E is currently undergoing Phase-3 clinical trials. The Covid-19 vaccine Biological E has reportedly shown promising results in Phase 1 and 2 clinical trials. Moreover, the vaccine being developed by Biological-E is a RBD protein sub-unit vaccine and is likely to be available in the next few months.
Currently, the Government of India is encouraging indigenous Vaccine manufacturers by supporting them in Research and Development (R&D) and financial aid to meet the vaccine demand of the country.
Flashback 2022 - Biggest Moments Of The Year The World Witnessed
According to NFHS, Alcohol consumption in men & women is higher in rural India than urban India. According to the survey, 1% of women aged 15 and above drink alcohol, compared to 19% of men in the same age group.
Odisha reported 51,968 forest fires between November 2020 and June 2021, which was the highest in the country during the period.
Tesla CEO and the current Twitter boss Elon Musk said that he would reverse the Twitter ban on former US president Donald Trump.
Flashback 2022 - Biggest Moments Of The Year The World Witnessed
According to NFHS, Alcohol consumption in men & women is higher in rural India than urban India. According to the survey, 1% of women aged 15 and above drink alcohol, compared to 19% of men in the same age group.
Copyright © 2024 - Odisha Television Limited All Rights Reserved.